Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
Jenell StewartKevin OwareDeborah DonnellLauren R VioletteJosephine OdoyoOlusegun O SogeCaitlin W ScovilleVictor OmolloFelix O MogakaFredericka A SesayR Scott McClellandMatthew SpinelliMonica GandhiElizabeth A BukusiJared M Baetennull nullPublished in: The New England journal of medicine (2023)
Among cisgender women, the incidence of STIs was not significantly lower with doxycycline PEP than with standard care. According to hair-sample analysis, the use of doxycycline PEP among those assigned to receive it was low. (Funded by the National Institutes of Health; dPEP ClinicalTrials.gov number, NCT04050540.).